These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1965950)

  • 21. Adherence of blood cells to dialyzer membranes as a measure of biocompatibility.
    Kjellstrand P; Okmark P; Odselius R; Thysell H; Riede G; Holmquist B
    Int J Artif Organs; 1991 Nov; 14(11):698-702. PubMed ID: 1757156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucocyte function tests during hemodialysis with different dialysis membranes.
    Bauer H; Brunner H; Franz HE; Bültmann B
    Contrib Nephrol; 1983; 36():9-14. PubMed ID: 6839778
    [No Abstract]   [Full Text] [Related]  

  • 26. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers.
    Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A
    Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
    Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD31 expression on leukocytes is downregulated in vivo during hemodialysis.
    Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki N; Tomimatsu I; Ushida Y; Hosono F; Maeda K
    Nephron; 2001 Oct; 89(2):153-60. PubMed ID: 11549897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes.
    Boran M; Bozdayi M; Cetin S
    Nephrol Dial Transplant; 1999 Jul; 14(7):1804-5. PubMed ID: 10435906
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of hemodialysis and dialyzer biocompatibility on erythrocyte glutathione-defense system in chronic hemodialysis patients.
    Alhamdani MS; Al-Najjar AF; Al-Kassir AH
    Int J Artif Organs; 2005 Jun; 28(6):576-82. PubMed ID: 16015567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
    Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA
    Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 34. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellulose membranes--time for a change?
    Henderson LW; Chenoweth DE
    Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
    [No Abstract]   [Full Text] [Related]  

  • 36. Biocompatibility of hemodialysis membranes.
    Cheung AK
    J Am Soc Nephrol; 1990 Aug; 1(2):150-61. PubMed ID: 2104259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
    Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
    Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay.
    Bingel M; Arndt W; Schulze M; Floege J; Shaldon S; Koch KM; Götze O
    Nephron; 1989; 51(3):320-4. PubMed ID: 2918943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of serum prealbumin following hemodialysis: effect of different dialysis membranes.
    Docci D; Bilancioni R; Pistocchi E; Baldrati L; Capponcini C; Delvecchio C; Feletti C
    Nephron; 1992; 62(2):145-9. PubMed ID: 1436305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.